Chemoinformaics analysis of N-Methyl-L-Anabasine
| Molecular Weight | 176.263 | nRot | 1 |
| Heavy Atom Molecular Weight | 160.135 | nRig | 12 |
| Exact Molecular Weight | 176.131 | nRing | 2 |
| Solubility: LogS | 0.33 | nHRing | 2 |
| Solubility: LogP | 1.343 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 31.2387 |
| nHD | 0 | BPOL | 18.9013 |
| QED | 0.652 |
| Synth | 2.468 |
| Natural Product Likeliness | -0.414 |
| NR-PPAR-gamma | 0.002 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.003 |
| HIA | 0.005 |
| CACO-2 | -4.289 |
| MDCK | 0.000015 |
| BBB | 0.964 |
| PPB | 0.220532 |
| VDSS | 2.666 |
| FU | 0.735354 |
| CYP1A2-inh | 0.167 |
| CYP1A2-sub | 0.921 |
| CYP2c19-inh | 0.165 |
| CYP2c19-sub | 0.955 |
| CYP2c9-inh | 0.021 |
| CYP2c9-sub | 0.498 |
| CYP2d6-inh | 0.3 |
| CYP2d6-sub | 0.901 |
| CYP3a4-inh | 0.338 |
| CYP3a4-sub | 0.721 |
| CL | 14.764 |
| T12 | 0.636 |
| hERG | 0.056 |
| Ames | 0.014 |
| ROA | 0.895 |
| SkinSen | 0.924 |
| Carcinogencity | 0.194 |
| EI | 0.055 |
| Respiratory | 0.969 |
| NR-Aromatase | 0.024 |
| Antiviral | No |
| Prediction | 0.718491 |